Immune Modulator

Cardiogen

Also known as: Ala-Glu-Asp-Arg

Cardiogen is a synthetic tetrapeptide (Ala-Glu-Asp-Arg / AEDR) from the Khavinson bioregulator series, studied in Russian preclinical models for potential effects on cardiac-tissue gene expression and cardiomyocyte structural proteins. Not FDA-approved; no Western clinical trials have been performed, and all published evidence originates from a single research group.